Literature DB >> 14569095

Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2.

Fabian Termorshuizen1, Johanna C Korevaar, Friedo W Dekker, Jeannette G Van Manen, Elisabeth W Boeschoten, Raymond T Krediet.   

Abstract

Various studies indicate that fair comparisons of mortality rates between hemodialysis (HD) patients and peritoneal dialysis (PD) patients are difficult because of differences in patient characteristics, because of nonconstant relative risks of death (RR), and because the survival times of patients who switch treatment modalities can be censored in different ways. The differences in mortality rates between HD and PD patients were investigated in an analysis in which these potential sources of bias were taken into account. The Netherlands Cooperative Study on the Adequacy of Dialysis is a multicenter, prospective, observational, cohort study in which new patients with ESRD are monitored until transplantation or death. A multivariate Cox regression analysis was used to analyze the mortality data according to treatment modality (HD, n = 742; PD, n = 480). No statistically significant differences in adjusted mortality rates between HD and PD patients were observed during the first 2 yr of dialysis. In the years thereafter, increases in mortality rates for PD patients and resulting decreases in RR in favor of HD were observed (e.g., months 24 to 36, adjusted RR, 0.53; 95% confidence interval, 0.31 to 0.91). This tendency was observed especially among patients >/=60 yr of age and was not influenced by the censoring strategy. These results suggest that long-term use of PD, especially among elderly patients, is associated with increases in mortality rates. Further analyses are required to determine the potential role of dialysis adequacy in the observed long-term differences in mortality rates between HD and PD patients and to establish the possible survival benefits for PD patients who switch to HD in time.

Entities:  

Mesh:

Year:  2003        PMID: 14569095     DOI: 10.1097/01.asn.0000091585.45723.9e

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  55 in total

1.  Dialysis: Dialysis modality and survival in ESRD--is the debate over?

Authors:  Angela Yee-Moon Wang
Journal:  Nat Rev Nephrol       Date:  2011-09-27       Impact factor: 28.314

2.  Prognosis of bedridden patients with end-stage renal failure after starting hemodialysis.

Authors:  Kimio Sugaya; Asanori Hokama; Eiri Hayashi; Hidekatsu Naka; Masami Oda; Saori Nishijima; Minoru Miyazato; Sanehiro Hokama; Yoshihide Ogawa
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

3.  Relationship between dialysis modality and mortality.

Authors:  Stephen P McDonald; Mark R Marshall; David W Johnson; Kevan R Polkinghorne
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

4.  Dialysis modality after renal transplant failure.

Authors:  Clare Castledine; Fergus J Caskey
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

Review 5.  [Peritoneal dialysis--an ideal initial dialysis mode].

Authors:  Heidi Puttinger
Journal:  Wien Med Wochenschr       Date:  2013-07-02

6.  Outcomes of dialytic modalities in a large incident registry cohort from Eastern Europe: the Romanian Renal Registry.

Authors:  Gabriel Mircescu; Gabriel Stefan; Liliana Gârneaţă; Irina Mititiuc; Dimitrie Siriopol; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2013-10-27       Impact factor: 2.370

7.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

8.  An Incident Cohort Study Comparing Survival on Home Hemodialysis and Peritoneal Dialysis (Australia and New Zealand Dialysis and Transplantation Registry).

Authors:  Annie-Claire Nadeau-Fredette; Carmel M Hawley; Elaine M Pascoe; Christopher T Chan; Philip A Clayton; Kevan R Polkinghorne; Neil Boudville; Martine Leblanc; David W Johnson
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-11       Impact factor: 8.237

Review 9.  Can peritoneal dialysis be used as a long term therapy for end stage renal disease?

Authors:  Michele Giannattasio; Michele Buemi; Flavia Caputo; Giusto Viglino; Enrico Verrina
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

10.  Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition.

Authors:  M A Schroijen; M W M van de Luijtgaarden; M Noordzij; P Ravani; F Jarraya; F Collart; K G Prütz; D G Fogarty; T Leivestad; F C Prischl; C Wanner; F W Dekker; K J Jager; O M Dekkers
Journal:  Diabetologia       Date:  2013-06-15       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.